What is NDC 55150-155?

55150-155 is the product NDC for Acyclovir Sodium, Acyclovir sodium 1000 mg/20mL injection, solution, listed with the FDA by AuroMedics Pharma LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

AuroMedics Pharma LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Acyclovir Sodium?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Acyclovir Sodium NDC 55150-155 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-155Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0155Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-155-21	5515001552155150015521	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-155-21) / 20 mL in 1 VIAL, SINGLE-DOSEMarketed from Oct 11, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acyclovir Sodium
Generic name (nonproprietary): acyclovir sodium
Active ingredients: Acyclovir sodium — 1000 mg/20mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: AuroMedics Pharma LLCNDC labeler code 55150
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203701
Marketing start: Oct 11, 2013
Listing expires: Dec 31, 2026
Other FDA classes: DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
Identifiers: Product ID 55150-155_ce906c2c-05e6-4356-995a-d2c95fd11787SPL ID ce906c2c-05e6-4356-995a-d2c95fd11787SPL set ID d3ab226c-677d-4cb7-85cb-1c2e5012f40dRxCUI 1734932, 1734934UNII 927L42J563UPC 0355150155217, 0355150154111
Pharmacologic class: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150015521 followed by a unit qualifier and the quantity

Package 55150-0155-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 18, 2017.

Indications (excerpt from the label)

INDICATIONS AND USAGE Herpes Simplex Infections in Immunocompromised Patients Acyclovir Sodium Injection is indicated for the treatment of initial and recurrent mucosal and cutaneous herpes simplex (HSV-1 and HSV-2) in immunocompromised patients. Initial Episodes of Herpes Genitalis Acyclovir Sodium Injection is indicated for the treatment of severe initial clinical episodes of herpes genitalis in immuno-competent patients. Herpes Simplex Encephalitis Acyclovir Sodium Injection is indicated for the treatment of herpes simplex encephalitis. Neonatal Herpes Simplex Virus Infection Acyclovir Sodium Injection is indicated for the treatment of neonatal herpes infections. Varicella-Zoster Infectio…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55150-155

What is NDC 55150-155?: 55150-155 is the product NDC for Acyclovir Sodium, Acyclovir sodium 1000 mg/20mL injection, solution, listed with the FDA by AuroMedics Pharma LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Acyclovir Sodium.
What is the active ingredient?: Acyclovir sodium.
Who is the labeler?: AuroMedics Pharma LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Acyclovir Sodium?: 2 other product NDCs are listed under this name. See all Acyclovir Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Acyclovir Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Acyclovir Sodium	Acyclovir sodium 500 mg/10mL	Injection, SolutionIntravenous	Eugia US LLC	55150-154	55150-0154-10
Acyclovir Sodium	Acyclovir sodium 1000 mg/20mL	Injection, SolutionIntravenous	ProPharma Distribution	84549-155	84549-0155-20

Other NDCs under ANDA 203701

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203701
Product	Strength	Form · route	Labeler	Product NDC
Acyclovir Sodium	Acyclovir sodium 500 mg/10mL	Injection, SolutionIntravenous	Eugia US LLC	55150-154
Acyclovir Sodium	Acyclovir sodium 1000 mg/20mL	Injection, SolutionIntravenous	ProPharma Distribution	84549-155